| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/20/2009 | EP2003116A9 Process for the production of organic oxides |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | CN101437800A Compounds and compositions as HEDGEHOG pathway modulators |
| 05/20/2009 | CN101437799A p38 MAP kinase inhibitors |
| 05/20/2009 | CN101437778A Reaction reagent for trifluoromethylation |
| 05/20/2009 | CN101434585A Amide derivatives as GK activators |
| 05/20/2009 | CN101434572A Prodrugs of GABA analogs, compositions and uses thereof |
| 05/20/2009 | CN101434517A Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/20/2009 | CN101433836A Catalyst for producing 3-cyano pyridine as well as preparation method and use thereof |
| 05/20/2009 | CN101433835A Mesoporous TiO2 supported V2O5 catalyst with high specific surface area as well as preparation method and use thereof |
| 05/20/2009 | CN100488362C Herbicidal composition |
| 05/19/2009 | US7534914 Substituted methyl aryl or heteroaryl amide compounds |
| 05/19/2009 | US7534814 Mutilin derivatives and their use as antibacterials |
| 05/19/2009 | US7534813 2-(4-substituted phenoxy)ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate orally coadministered with a decarboxylase inhibitor or a catechol O-methyltransferase inhibitor; improved bioavailability when administered in the colon; sustained release; sleep disorders; nervous system disorders |
| 05/19/2009 | US7534802 Compounds having 4-pyridylalkylthio group as substituent |
| 05/19/2009 | US7534506 Luminescence device, display apparatus and metal coordination compound |
| 05/19/2009 | CA2364801C Pyridazin-3-one derivatives and medicines containing the same |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009061744A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | WO2009060160A1 P38 map kinase inhibitors |
| 05/14/2009 | WO2009018909A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 05/14/2009 | WO2008066558A3 Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines |
| 05/14/2009 | US20090124671 Trpv1 antagonists |
| 05/14/2009 | US20090124669 Structural Analogues of Avenanthramides, Their Use in Compositions Useful in the Treatment of Dermatological Disorders |
| 05/14/2009 | US20090124665 Potassium Channel Inhibitors |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
| 05/14/2009 | US20090124602 Kinase inhibitors |
| 05/14/2009 | US20090123369 Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques |
| 05/14/2009 | US20090121620 Organometallic complex, organic el element and organic el display |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | CA2704473A1 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/13/2009 | EP2058302A1 Method for producing phenoxypyridine derivative |
| 05/13/2009 | EP2057174A1 New cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions |
| 05/13/2009 | EP2057121A2 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
| 05/13/2009 | EP2057118A2 Compounds for treatment of proliferative disorders |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives |
| 05/13/2009 | EP1565429B1 Diaryl ureido derivatives and their medical use |
| 05/13/2009 | EP1377570B1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor |
| 05/13/2009 | CN101429194A Process for the preparation of tryptase inhibitors |
| 05/13/2009 | CN101429151A IDO restrainer containing (E)-4-(beta-bromo vinyl)benzoyloxy structure |
| 05/13/2009 | CN100486982C Compound possessing function for preventing and curing thrombus disease, its pharmacy composition and usage in medication |
| 05/13/2009 | CN100486981C Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science |
| 05/13/2009 | CN100486976C Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/12/2009 | US7531695 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators |
| 05/07/2009 | WO2009058348A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | WO2009056600A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | WO2009055869A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/07/2009 | WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues |
| 05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
| 05/07/2009 | WO2009009041A3 Compositions and methods for modulating a kinase cascade |
| 05/07/2009 | WO2008088540A4 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
| 05/07/2009 | US20090118338 Aryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/07/2009 | US20090118333 Amides useful as inhibitors of voltage-gated sodium channels |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118307 Aryl Sulfonamides |
| 05/07/2009 | US20090118291 Histone deacetylase inhibitors |
| 05/07/2009 | US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090117586 Fungal cell wall synthesis gene |
| 05/07/2009 | US20090117185 2-(Aminomethyl)-5-Chlorobenzylamide Derivatives and their use as Inhibitors of the Clotting Factor Xa |
| 05/07/2009 | US20090113639 For coloring keratin fibers, human hair |
| 05/07/2009 | DE102008030947A1 Agent, useful for coloring keratin fibers, preferably human hairs, animal hairs, wool, horse hair, angora hair, fur, feathers or textiles, comprises 4-(3-(1H-pyridin-4-ylidene)-cyclopenta-1,4-dienyl )-pyridinium compound as a direct dye |
| 05/07/2009 | CA2704336A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | CA2704250A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/07/2009 | CA2703909A1 P2x3, receptor antagonists for treatment of pain |
| 05/07/2009 | CA2690976A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/06/2009 | EP2055689A1 Method for producing an optically active nitro compound |
| 05/06/2009 | EP2054429A2 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 05/06/2009 | EP2054388A1 Viral polymerase inhibitors |
| 05/06/2009 | EP2054387A1 Process for the manufacture of hi-6 dimethanesulfonate |
| 05/06/2009 | EP2054386A2 Non-flushing niacin analogues, and methods of use thereof |
| 05/06/2009 | EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/06/2009 | EP2054380A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/06/2009 | EP1651607B1 6-(1,1-difluoroalkyl)-4-aminopicolinates and their use as herbicides |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1373265B1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 05/06/2009 | CN101426793A Methods for the preparation of hcv polymerase inhibitors |
| 05/06/2009 | CN101426766A Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100484924C Process for preparation of phenoxy-substituted 2-pyridone compounds |
| 05/05/2009 | US7528274 For therapy of viral infections, particularly those caused by retroviruses |
| 05/05/2009 | US7528260 Method for preparing N-phenylpyrazole-1-carboxamides |
| 05/05/2009 | US7528256 Process for the preparation of nicotinaldehydes |